Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
EMMESSA •BSE
Emmessar Biotech & Nutrition
₹23.92-0.37 (1.52%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
23.54
Today’s high
24.29
52 week low
18.42
52 week high
42.75
Open price
24.29
Previous close
24.29
Live volume
429
Lower circuit
19.14
Upper circuit
28.70
Fundamentals
Market Cap
₹12Cr
ROE
5.37%
P/E Ratio(TTM)
30.75
EPS(TTM)
0.79
P/B Ratio
1.50
Dividend Yield
0.00%
Industry P/E
41.01
Book Value
16.24
Debt to Equity
0.00
Face Value
10
Financial performance
JUN '26
Revenue (Cr)
₹0.60
+7.14%
Profit (Cr)
₹0.13
+333.33%
050 L11.52
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -3% |
| 3Y CAGR | +5% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -24% |
| 3Y CAGR | -13% |
About
Emmessar Biotech & Nutrition Ltd. operates in the global healthcare and nutritional products industry, adapting to growing consumer interest in holistic medicine. The company's distinct strategy is built around 'VedaCeuticals', a concept that fuses ancient Ayurveda with modern pharmaceuticals. This method involves programming food ingredients to serve as both body-building nutrition and as medicine for curing diseases. It actively manufactures CalmCream and also trades other brands like Cute-n-Comely, Magicream, and Muscle Flex Gel through a partner company. This dual focus on manufacturing and trading allows the company to serve a wide variety of healthcare needs and expand its market presence. EBNL has also made significant progress by developing a dedicated e-commerce platform to improve the sale and distribution of its healthcare products.;
CEO/MD
Mr. Srinivasa Raghavan Mathurakavi Ayyangar
Founded in
1992
BSE symbol
524768
Shareholding pattern
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,978.20 +58.20 (1.18%) | 22,514.29 | 30.62 | 5.36 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,560.80 +31.10 (1.23%) | 19,234.00 | 28.37 | 5.36 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,415.50 -91.50 (1.22%) | 18,760.75 | 110.6 | 21.5 | ||
Natco PharmaNATCOPHARM | ₹882.40 +4.90 (0.56%) | 15,721.37 | 13.73 | 1.7 |
2026
7
Aug
Quarterly Result
Release date
12
May
Quarterly & Annual Result
Release date
11
Feb
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
7
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks